Loading...
Nuvation Bio Inc.
NUVB-WT•NYSE
HealthcareBiotechnology
$0.27
$0.05(22.67%)
Nuvation Bio Inc. (NUVB-WT) Company Profile & Overview
Explore Nuvation Bio Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Nuvation Bio Inc. (NUVB-WT) Company Profile & Overview
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
SectorHealthcare
IndustryBiotechnology
Contact Information
New York City, DE
Company Facts
220 Employees
CountryUS
Actively Trading